The cost of being wrong is not the same everywhere
A retail forecasting model that's wrong produces a stocking error. A fraud model that's wrong produces a false positive that annoys a customer. A clinical decision-support tool that's wrong can produce the wrong treatment, the wrong dosage, or a missed diagnosis. The same evidence-quality failures that are merely expensive in other sectors are dangerous in healthcare, and the verification standard has to reflect that difference, not treat every dataset as equally forgiving.
This isn't a reason to avoid data-driven tools in healthcare. It's a reason to be explicit about what "verified" has to mean before those tools touch a clinical decision.
Where unverified data actually enters clinical systems
Three points are where the gap usually opens. Device and sensor data — vitals monitoring, diagnostic equipment output — arrives trustworthy only if the device is calibrated and maintained on a documented schedule, not assumed accurate because it's digital. Patient-reported and administratively-entered data carries transcription error, incomplete history, and inconsistent coding that a downstream model has no way to detect unless the data pipeline flags it explicitly. And third-party or aggregated datasets used to train or validate predictive tools carry whatever quality problems existed in the original collection, inherited silently unless someone traces the lineage back before trusting the aggregate.
Each of these can look identical to clean data once it reaches a dashboard or a model output. The difference only shows up if someone built the pipeline to preserve and surface it.
What verification has to mean in this setting
The general standard — source, collection method, transformation, audit trail — still applies, but healthcare adds a requirement most sectors don't need: a human clinical reviewer in the loop for anything that reaches a treatment decision, with their reasoning captured alongside the tool's output, not replacing it. A predictive tool that flags a risk is a input to clinical judgment. It is not a substitute for it, and treating it as one is exactly the failure mode that turns a useful tool into a patient-safety incident waiting to be reported.
Audit trail requirements are also stricter here for a specific reason: when something goes wrong in healthcare, the reconstruction of what the system knew and when it's needed for both clinical review and, potentially, regulatory or legal accountability. A fraud team can usually live with an audit trail that takes a day to reconstruct. A clinical incident review cannot.
Why this matters more as AI enters clinical workflows
AI-powered diagnostic and decision-support tools are being adopted across African healthcare systems at real pace, often as a genuine improvement in access — extending specialist-level triage into settings that don't have specialists on staff. That promise is real. It's also exactly the scenario where unverified inputs do the most damage, because the tool is often filling a gap where there's no second clinical opinion readily available to catch an error.
Governance before scale applies here with the least room for exception. An institution deploying AI-powered clinical tools needs verified data pipelines, documented calibration and maintenance for any connected devices, and a clear human-review requirement built in before the tool touches a real patient — not layered on afterward once the first preventable error surfaces.